Successful treatment with secukinumab in an HIV-positive psoriatic patient after failure of apremilast

Paolo Romita; Caterina Foti; Gianluca Calianno; Andrea Chiricozzi

doi:10.1111/dth.15610

Successful treatment with secukinumab in an HIV-positive psoriatic patient after failure of apremilast

Paolo Romita, Caterina Foti, Gianluca Calianno, Andrea Chiricozzi

University of Bari

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Lingua originale	English
pagine (da-a)	e15610-N/A
Rivista	Dermatologic Therapy
Volume	35
DOI	https://doi.org/10.1111/dth.15610
Stato di pubblicazione	Pubblicato - 2022

Keywords

Antibodies, Monoclonal, Humanized
Antirheumatic Agents
Arthritis, Psoriatic
HIV Infections
Humans
Thalidomide
Treatment Outcome

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1111/dth.15610

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{5bf89a5a161745ddb10409a0aeab654e,

title = "Successful treatment with secukinumab in an HIV-positive psoriatic patient after failure of apremilast",

keywords = "Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Arthritis, Psoriatic, HIV Infections, Humans, Thalidomide, Treatment Outcome, Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Arthritis, Psoriatic, HIV Infections, Humans, Thalidomide, Treatment Outcome",

author = "Paolo Romita and Caterina Foti and Gianluca Calianno and Andrea Chiricozzi",

year = "2022",

doi = "10.1111/dth.15610",

language = "English",

volume = "35",

pages = "e15610--N/A",

journal = "Dermatologic Therapy",

issn = "1396-0296",

publisher = "Malden, MA: Blackwell Science Incorporated Copenhagen: Munksgaard",

}

TY - JOUR

T1 - Successful treatment with secukinumab in an HIV-positive psoriatic patient after failure of apremilast

AU - Romita, Paolo

AU - Foti, Caterina

AU - Calianno, Gianluca

AU - Chiricozzi, Andrea

PY - 2022

Y1 - 2022

KW - Antibodies, Monoclonal, Humanized

KW - Antirheumatic Agents

KW - Arthritis, Psoriatic

KW - HIV Infections

KW - Humans

KW - Thalidomide

KW - Treatment Outcome

KW - Antibodies, Monoclonal, Humanized

KW - Antirheumatic Agents

KW - Arthritis, Psoriatic

KW - HIV Infections

KW - Humans

KW - Thalidomide

KW - Treatment Outcome

UR - http://hdl.handle.net/10807/214031

U2 - 10.1111/dth.15610

DO - 10.1111/dth.15610

M3 - Article

SN - 1396-0296

VL - 35

SP - e15610-N/A

JO - Dermatologic Therapy

JF - Dermatologic Therapy

ER -